| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 03/15/2011 | CA2528385C A1 adenosine receptor antogonists |
| 03/15/2011 | CA2472586C Use of polysaccharide derivatives as antiinfective substances |
| 03/15/2011 | CA2458266C Substituted urea retinoid agonists ii |
| 03/15/2011 | CA2433806C Methods for treating autoimmune diseases in a subject and in vitro diagnostic assays |
| 03/15/2011 | CA2431160C Anilinopyrimidine derivatives as ikk inhibitors and compositions and methods related thereto |
| 03/15/2011 | CA2429134C A method for generating genetically altered antigens |
| 03/15/2011 | CA2422375C 3-(heteroaryl acetamido)-2-oxo-azetidine-1-sulfonic acids derivatives as antibacterial agents |
| 03/15/2011 | CA2410297C Assembly of wild-type and chimeric influenza virus-like particles (vlps) |
| 03/15/2011 | CA2406008C Composition exhibiting enhanced formulation stability and delivery of topical active ingredients |
| 03/15/2011 | CA2394809C Benzazole derivatives and their use as jnk modulators |
| 03/15/2011 | CA2389302C Delivery of proteins across polar epithelial cell layers |
| 03/15/2011 | CA2380833C Proteins derived from white spot syndrome virus and uses thereof |
| 03/15/2011 | CA2373653C New use of compounds as antibacterial agents |
| 03/15/2011 | CA2277192C Nuclear transfer with differentiated fetal and adult donor cells |
| 03/10/2011 | WO2011028963A2 Immunogenic hiv composition |
| 03/10/2011 | WO2011028811A2 Dual variable domain immunoglobulins and uses thereof |
| 03/10/2011 | WO2011028673A2 A composition for delaying cellular senescence |
| 03/10/2011 | WO2011028485A2 Tumoricidal, bactericidal, or viricidal macrophage activation |
| 03/10/2011 | WO2011028173A1 Method of treatment of a patient suffering from an infection or injuries caused or complicated by infection |
| 03/10/2011 | WO2011028064A2 Novel bacteriophage and antibacterial composition comprising the same |
| 03/10/2011 | WO2011028061A2 Novel bacteriophage and antibacterial composition comprising the same |
| 03/10/2011 | WO2011028059A2 Novel bacteriophage and antibacterial composition comprising the same |
| 03/10/2011 | WO2011028057A2 Novel bacteriophage and antibacterial composition comprising the same |
| 03/10/2011 | WO2011027971A2 Gut flora-derived extracellular vesicles, and method for searching for a disease model, vaccine, and candidate drug and for diagnosis using same |
| 03/10/2011 | WO2011027875A1 Agent for improving intestinal tract barrier function |
| 03/10/2011 | WO2011027829A1 Composition containing rna derived from lactic acid bacterium as active ingredient |
| 03/10/2011 | WO2011027324A1 Polymorphic forms of atazanavir sulfate |
| 03/10/2011 | WO2011027290A1 Antibiotic compounds |
| 03/10/2011 | WO2011027156A1 Benzodiazepine derivatives for treating hepatitis c infection |
| 03/10/2011 | WO2011027046A1 Use of secnidazole in combination with an active antibiotic against aerobic bacteria for treating diverticulitis |
| 03/10/2011 | WO2011026920A1 Bis-benzimidazole derivatives |
| 03/10/2011 | WO2011026529A1 Novel antibacterial hydroxyphenyl compound |
| 03/10/2011 | WO2011026447A1 New antibiotic containing simulacrum antibody, preparation method and application thereof |
| 03/10/2011 | WO2011026351A1 A cyanovirin n mutant, modified derivative and uses thereof |
| 03/10/2011 | WO2010148511A8 Chimeric influenza virus-like particles comprising hemagglutinin |
| 03/10/2011 | WO2010129947A3 Alpha thymosin peptides as vaccine enhancers |
| 03/10/2011 | WO2010129347A3 Compositions and methods for the treatment of disorders involving epithelial cell apoptosis |
| 03/10/2011 | WO2010118367A3 Antiviral pyrimidines |
| 03/10/2011 | WO2010114628A3 Formulation for inducing broadly reactive neutralizing anti-hiv antibodies |
| 03/10/2011 | WO2010111718A3 Antiviral compounds and methods of use thereof |
| 03/10/2011 | WO2010107742A3 Methods and compositions of treating a flaviviridae family viral infection |
| 03/10/2011 | WO2010107739A3 Methods and compositions of treating a flaviviridae family viral infection |
| 03/10/2011 | WO2010074721A3 Anitmicrobial agents, compositions and products containing the same, and methods of using the compositions and products |
| 03/10/2011 | US20110061136 Fusion protein that directs vaccine antigens to antigen-presenting cells, and applications thereof |
| 03/10/2011 | US20110061114 Novel pro258 gene disruptions, and methods relating thereto |
| 03/10/2011 | US20110060050 Sgk1 inhibitors for the prophylaxis and/or therapy of viral diseases and/or carcinomas |
| 03/10/2011 | US20110060044 Aliphatic acid-containing n-halogenated amino acid formulations |
| 03/10/2011 | US20110060031 Compositions And Methods For Inhibiting Expression Of A Gene From The Ebola Virus |
| 03/10/2011 | US20110060024 Modulators of ATP-Binding Cassette Transporters |
| 03/10/2011 | US20110060007 Novel NIP Thiazole Derivatives as Inhibitors of 11-Beta-Hydroxysteroid Dehydroge-Nase-1 |
| 03/10/2011 | US20110059995 Substituted xanthine derivatives |
| 03/10/2011 | US20110059989 3,5-diamino-6-chloro-pyrazine-2-carboxylic acid derivatives and their use as epithelial sodium channel blockers for the treatment of airway diseases |
| 03/10/2011 | US20110059987 Co-Crystals and Pharmaceutical Compositions Comprising the Same |
| 03/10/2011 | US20110059985 Novel formulation |
| 03/10/2011 | US20110059978 Pyridazinyl amine derivatives, the use thereof in the preparation of picorna virus inhibitors |
| 03/10/2011 | US20110059977 USE OF CANTHIN-6-ONE AND ITS ANALOGS IN THE TREATMENT OF MYCOBACTERIA-LINKED PATHOLOGIES ( amended |
| 03/10/2011 | US20110059976 Pyrido pyrimidinones, dihydro pyrimido pyrimidinones and pteridinones useful as raf kinase inhibitors |
| 03/10/2011 | US20110059975 Non-nucleoside reverse transcriptase inhibitors |
| 03/10/2011 | US20110059973 Pyrazole Compounds for Controlling Invertebrate Pests |
| 03/10/2011 | US20110059962 Transcription factor modulating compounds and methods of use thereof |
| 03/10/2011 | US20110059952 3-substituted-1,4-diazepan-2-one melanocortin-5 receptor antagonists |
| 03/10/2011 | US20110059950 Aniline derivative having anti-rna viral activity |
| 03/10/2011 | US20110059949 Prophylaxis and treatment of infectious diseases |
| 03/10/2011 | US20110059948 Quinoline, naphthalene and conformationally constrained quinoline or naphthalene derivatives as anti-mycobacterial agents |
| 03/10/2011 | US20110059946 Dual action antibiotics |
| 03/10/2011 | US20110059938 New chemical compounds |
| 03/10/2011 | US20110059937 Il-8 receptor antagonists |
| 03/10/2011 | US20110059935 Beta-LACTAMYL VASOPRESSIN V1a ANTAGONISTS |
| 03/10/2011 | US20110059933 Crystalline sodium salt of cephalosporin antibiotic |
| 03/10/2011 | US20110059921 Oligomer-Nitrogenous Base Conjugates |
| 03/10/2011 | US20110059919 Antiviral composition comprising a sulfated polysaccharide |
| 03/10/2011 | US20110059911 Antiinfective and Antitumoral Compounds Isolated From Tropical Lianas |
| 03/10/2011 | US20110059531 Method for expression of small rna molecules within a cell |
| 03/10/2011 | US20110059194 Echinacea formulation |
| 03/10/2011 | US20110059190 Cistus extract containing enriched secondary plant ingredients |
| 03/10/2011 | US20110059189 Method and composition for treating cancer, effecting apoptosis and treating retroviral infections |
| 03/10/2011 | US20110059175 Enhancing solubility and dissolution rate of poorly soluble drugs |
| 03/10/2011 | US20110059167 Encapsulation of biologically active agents |
| 03/10/2011 | US20110059162 Tannin-chitosan composites |
| 03/10/2011 | US20110059159 Nanoscale bound bilayers, methods of use and production |
| 03/10/2011 | US20110059158 Charged phospholipid compositions and methods for their use |
| 03/10/2011 | US20110059154 Ccr5 antagonists as prophylactics for preventing hiv infection and methods of inhibiting transmission of same |
| 03/10/2011 | US20110059147 Long term drug delivery devices with polyurethane based polymers and their manufacture |
| 03/10/2011 | US20110059138 Compositions and methods for enhancing immune system of felines |
| 03/10/2011 | US20110059136 Methods and Compositions for Treating Inflammatory Bowel Disease |
| 03/10/2011 | US20110059134 Prevention of recurrent viral disease |
| 03/10/2011 | US20110059132 Composition for therapy and/or for prophylaxis of hbv-infections and hbv-mediated diseases |
| 03/10/2011 | US20110059131 Localization and characterization of flavivirus envelope glycoprotein cross-reactive epitopes and methods for their use |
| 03/10/2011 | US20110059130 Prophylactic and therapeutic influenza vaccines, antigens, compositions and methods |
| 03/10/2011 | US20110059129 Avian influenza virus vaccine and a method for preparing |
| 03/10/2011 | US20110059128 Vaccine composition for vaccinating dogs against canine infectious respiratory disease (cird) |
| 03/10/2011 | US20110059127 Use of mutant hiv-1 protease or siv protease as an adjuvant |
| 03/10/2011 | US20110059126 Methods of reducing virucidal activity in pcv-2 compositions and pcv-2 compositions with an improved immunogenicity |
| 03/10/2011 | US20110059120 Glucan-based vaccines |
| 03/10/2011 | US20110059119 Immunogen against campylobacter infection |
| 03/10/2011 | US20110059117 Liquid Compositions Capable of Foaming and Including Active Agents, and Methods for Making or Developing Same |
| 03/10/2011 | US20110059116 Laser-based vaccine adjuvants |
| 03/10/2011 | US20110059111 Mammalian receptors as targets for antibody and active vaccination therapy against mold infections |
| 03/10/2011 | US20110059098 Human Anthrax Toxin Neutralizing Monoclonal Antibodies and Methods of Use Thereof |
| 03/10/2011 | US20110059086 Espfu nucleic acids and proteins and uses thereof |